Tatva Chintan board to review Q2 and H1 financial results

Tatva Chintan Pharma Chem Limited has announced that its board of directors will convene on Friday, October 31, 2025. The primary agenda for this meeting is to consider, approve, and take on record the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025.

In accordance with the company's code of conduct for prohibition of insider trading, a trading window closure has been communicated to designated persons. This closure commenced on October 1, 2025, and will remain in effect until 48 hours after the public disclosure of the financial results.

This information is available on the company's website, www.tatvachintan.com. The communication was sent to both BSE Limited and the National Stock Exchange of India Limited.